{
    "id": 27458,
    "fullName": "CHEK1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CHEK1 over exp indicates an over expression of the Chek1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1111,
        "geneSymbol": "CHEK1",
        "terms": [
            "CHEK1",
            "CHK1"
        ]
    },
    "variant": "over exp",
    "createDate": "01/24/2018",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12744,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, small cell lung cancer cell lines, which expressed high levels of CHEK1, demonstrated sensitivity to VX-970 treatment, resulting in decreased viability in culture and reduced tumor growth in xenograft models (PMID: 29138515).",
            "molecularProfile": {
                "id": 28910,
                "profileName": "CHEK1 over exp"
            },
            "therapy": {
                "id": 2879,
                "therapyName": "VX-970",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10681,
                    "pubMedId": 29138515,
                    "title": "Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29138515"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12743,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, small cell lung cancer cell lines, which expressed high levels of CHEK1, demonstrated sensitivity to PF-00477736 treatment, resulting in decreased viability in culture and reduced tumor growth in xenograft models (PMID: 29138515).",
            "molecularProfile": {
                "id": 28910,
                "profileName": "CHEK1 over exp"
            },
            "therapy": {
                "id": 1565,
                "therapyName": "PF-00477736",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10681,
                    "pubMedId": 29138515,
                    "title": "Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29138515"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28910,
            "profileName": "CHEK1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}